Rapid communication: Amylin and hypertension: Association of an amylin -G132A gene mutation and hypertension in humans and amylin-induced endothelium dysfunction in rats

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 4, 2007, Pages 1446-1450

  Novials, Anna ^a   Rodriguez Mañas, Leocadio ^b   Chico, Ana ^a   El Assar, Mariam ^b   Casas, Sílvia ^a,c   Gomis, Ramon ^c  

^a Sarda Farriol Foundation   (Spain)

^b HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; AMYLIN; N(G) NITROARGININE METHYL ESTER; AMYLOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIAL DYSFUNCTION; FEMALE; GENE MUTATION; GENETIC SCREENING; HETEROZYGOTE DETECTION; HUMAN; HYPERTENSION; INCUBATION TIME; MAJOR CLINICAL STUDY; MALE; MESENTERY BLOOD VESSEL; MICROVASCULATURE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; VASCULAR RING; AGED; ANIMAL; DRUG EFFECT; GENETICS; MIDDLE AGED; MUTATION; PATHOPHYSIOLOGY; RAT; REFERENCE VALUE; SINGLE NUCLEOTIDE POLYMORPHISM; SPRAGUE DAWLEY RAT; VASCULAR ENDOTHELIUM;

RATTUS;

AGED; AMYLOID; ANIMALS; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES;

EID: 34147111456     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-1980     Document Type: Article

References (25)

1. Kahn SE, D'Alessio DA, Schwartz MW, Fujimoto WY, Ensinck JW, Taborsky GJ, Porte D 1990 Evidence of cosecretion of islet amyloid polypeptide and insulin by β-cells. Diabetes 39:634-638
2. Leighton B, Cooper GSJ 1988 Pancreatic IAPP and calcitonin gene related peptide cause resistance to insulin in skeletal muscle in vitro. Nature 335:632-635
3. Ludvik B, Thomaseth K, Nolan JJ, Clodi M, Prager R, Pacini G 2003 Inverse relation between amylin and glucagon secretion in healthy and diabetic human subjects. Eur J Clin Invest 33:316-322
4. Young AA, Gedulin B, Vine W, Percy A Rink TJ 1995 Gastric emptying is accelerated in diabetic BB rats and is slowed by subcutaneous injections of amylin. Diabetologia 38:642-648
5. Cooper GJS, Willis AC, Clark A, Turner RC, Sim RB, Reid KBM 1987 Purification and characterization of a peptide from amyloid rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci USA 84:8628-8632
6. Cooper ME, McNally PG, Phillips PA, Johnston CI 1995 Amylin stimulates plasma renin concentration in humans. Hypertension 26:460-464
7. Haynes JM, Hodgson WC, Cooper ME 1997 Rat amylin mediates a pressor response in the anaesthetised rat: implications for the association between hypertension and diabetes mellitus. Diabetologia 40:256-261
8. Ikeda T, Iwata K, Ochi H 2001 Effect of insulin, proinsulin and amylin on renin release from perfused rat kidney. Metabolism 50:763-766
9. Kailasam MT, Parmer RJ, Tyrell EA, Henry RR, O'Connor DT 2000 Circulating amylin in human essential hypertension: heritability and early increase in individuals at genetic risk. J Hypertens 18:1611-1620
10. Novials A, Rojas I, Casamitjana R, Usac EF, Gomis R 2001 A novel mutation in islet amyloid polypeptide (IAPP) gene promoter is associated with type 2 diabetes mellitus. Diabetologia 44:1064-1065
11. Poa NR, Cooper GJ, Edgar PF 2003 Amylin gene promoter mutations predispose to type 2 diabetes in New Zealand Maori. Diabetologia 46:574-578
12. Esapa C, Moffitt JH, Novials A, McNamara CM, Levy JC, Laakso M, Gomis R, Clark A 2005 Islet amyloid polypeptide gene promoter polymorphisms are not associated with type 2 diabetes or with the severity of islet amyloidosis. Biochim Biophys Acta 1740:74-78
13. Novials A, Mato E, Lu cas M, Franco C, Rivas M, Santiesteban P, Gomis R 2004 Mutation at position -132 in the islet amyloid polypeptide (IAPP) gene promoter enhances basal transcriptional activity through a new CRE-like binding site. Diabetologia 47:1167-1174
14. American Diabetes Association 2006 Standards of medical care in diabetes-2006. Diabetes Care 29(Suppl 1):S5-S42
15. Rodríguez-Mañas L, Angulo J, Vallejo S, Peiró C, Sánchez-Ferrer A, Cercas E, Llergo JL, López-Dóriga P, Sánchez-Ferrer CF 2003 Early and intermediate glycosylation products, oxidative stress, and endothelial dysfunction in the streptozotocin-induced diabetic rats vasculature. Diabetologia 46:556-566
16. Rodríguez-Mañas L, Arribas S, Girón MC, Villamor J, Sánchez-Ferrer CF, Mar?́n J 1993 Interference of glycosylated human hemoglobin with endothelium-dependent responses. Circulation 88:2111-2116
17. Angulo J, Sánchez-Ferrer CF, Peiró C, Marín J, Rodríguez-Mañas L 1996 Impairment of endothelium-dependent relaxation by increasing percentages of glycosylated human hemoglobin. Possible mechanisms involved. Hypertension 28:583-585
18. Ludvik B, Lell B, Hartter E, Schnack C, Prager R 1991 Decrease of stimulated amylin release precedes impairment of insulin secretion in type 2 diabetes. Diabetes 40:1615-1619
19. Kautzky-Willer A, Thomaseth K, Ludvik B, Nowotny P, Rabensteiner D, Waldhausl W, Pacini G, Prager R 1997 Elevated islet amyloid polypeptide and proinsulin in lean gestational diabetes. Diabetes 46:607-614
20. Kautzky-Willer A, Thomaseth K, Pacini G, Clodi M, Ludvik B, Streli C, Waldhausl W, Prager R 1994 Role of islet amyloid polypeptide secretion in insulin-resistant humans. Diabetologia 37:188-194
21. Harris PJ, Cooper ME, Hiranyachattada S, Berka JL, Kelly DJ, Nobes M, Wookey PJ 1977 Amylin stimulates proximal tubular sodium transport and cell proliferation in the rat kidney. Am J Physiol 272:F13-F21
22. Konarkowska B, Aitken JF, Kistler J, Zhang S, Cooper GJS 2005 Thiol reducing compounds prevent human amylin-evoked cytotoxicity. FEBS J 272: 4949-4959
23. Luk'yantseva GV, Sergeev IY, Kopylova GN, Samonina GE, German SV 2001 Effect of amylin on the tone of rat aorta ring preparation. Bull Exp Biol Med 132:932-934
24. Westfall TC, Curfman-Falvey M 1995 Amylin-induced relaxation of the perfused mesenteric arterial bed: mediation by CGRP receptors. J Cardiovasc Pharmacol 26:932-936
25. Champion HC, Pierce RL, Bivalacqua TJ, Murphy WA, Coy DH, Kadowitz PJ 2001 Analysis of responses to hAmylin, hCGRP, and hADM in isolated resistance arteries from the mesenteric vascular bed of the rat. Peptides 22:1427-1434